BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15962004)

  • 1. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.
    Matsumoto T; Bohman S; Dixelius J; Berge T; Dimberg A; Magnusson P; Wang L; Wikner C; Qi JH; Wernstedt C; Wu J; Bruheim S; Mugishima H; Mukhopadhyay D; Spurkland A; Claesson-Welsh L
    EMBO J; 2005 Jul; 24(13):2342-53. PubMed ID: 15962004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.
    Matsumoto T; Mugishima H
    J Atheroscler Thromb; 2006 Jun; 13(3):130-5. PubMed ID: 16835467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
    Sun Z; Li X; Massena S; Kutschera S; Padhan N; Gualandi L; Sundvold-Gjerstad V; Gustafsson K; Choy WW; Zang G; Quach M; Jansson L; Phillipson M; Abid MR; Spurkland A; Claesson-Welsh L
    J Exp Med; 2012 Jul; 209(7):1363-77. PubMed ID: 22689825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endothelial adaptor molecule TSAd is required for VEGF-induced angiogenic sprouting through junctional c-Src activation.
    Gordon EJ; Fukuhara D; Weström S; Padhan N; Sjöström EO; van Meeteren L; He L; Orsenigo F; Dejana E; Bentley K; Spurkland A; Claesson-Welsh L
    Sci Signal; 2016 Jul; 9(437):ra72. PubMed ID: 27436360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation.
    Manni S; Kisko K; Schleier T; Missimer J; Ballmer-Hofer K
    FASEB J; 2014 Nov; 28(11):4914-23. PubMed ID: 25114179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased placental angiogenesis in late and early onset pre-eclampsia is associated with differential activation of vascular endothelial growth factor receptor 2.
    Escudero C; Celis C; Saez T; San Martin S; Valenzuela FJ; Aguayo C; Bertoglia P; Roberts JM; Acurio J
    Placenta; 2014 Mar; 35(3):207-15. PubMed ID: 24508097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
    Dixelius J; Makinen T; Wirzenius M; Karkkainen MJ; Wernstedt C; Alitalo K; Claesson-Welsh L
    J Biol Chem; 2003 Oct; 278(42):40973-9. PubMed ID: 12881528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.
    Mannell HK; Pircher J; Chaudhry DI; Alig SK; Koch EG; Mettler R; Pohl U; Krötz F
    Cardiovasc Res; 2012 Jan; 93(1):111-9. PubMed ID: 22002459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.
    Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F
    Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
    Meyer RD; Sacks DB; Rahimi N
    PLoS One; 2008; 3(12):e3848. PubMed ID: 19050761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of the T cell-specific adapter protein in the activation of LCK in peripheral T cells.
    Marti F; Garcia GG; Lapinski PE; MacGregor JN; King PD
    J Exp Med; 2006 Feb; 203(2):281-7. PubMed ID: 16446380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity.
    Kawamura H; Li X; Harper SJ; Bates DO; Claesson-Welsh L
    Cancer Res; 2008 Jun; 68(12):4683-92. PubMed ID: 18559514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adapter protein, Grb10, is a positive regulator of vascular endothelial growth factor signaling.
    Giorgetti-Peraldi S; Murdaca J; Mas JC; Van Obberghen E
    Oncogene; 2001 Jul; 20(30):3959-68. PubMed ID: 11494124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G13 controls angiogenesis through regulation of VEGFR-2 expression.
    Sivaraj KK; Takefuji M; Schmidt I; Adams RH; Offermanns S; Wettschureck N
    Dev Cell; 2013 May; 25(4):427-34. PubMed ID: 23664862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-redundant roles of the Gab1 and Gab2 scaffolding adapters in VEGF-mediated signalling, migration, and survival of endothelial cells.
    Caron C; Spring K; Laramée M; Chabot C; Cloutier M; Gu H; Royal I
    Cell Signal; 2009 Jun; 21(6):943-53. PubMed ID: 19233262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SALM4 regulates angiogenic functions in endothelial cells through VEGFR2 phosphorylation at Tyr1175.
    Kim DY; Park JA; Kim Y; Noh M; Park S; Lie E; Kim E; Kim YM; Kwon YG
    FASEB J; 2019 Sep; 33(9):9842-9857. PubMed ID: 31170000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
    Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
    Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells.
    Sikkema AH; de Bont ES; Molema G; Dimberg A; Zwiers PJ; Diks SH; Hoving EW; Kamps WA; Peppelenbosch MP; den Dunnen WF
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):538-48. PubMed ID: 21208252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.